Bowman, Simon

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Abani, O., Abbas, A., Abbas, F., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., et al. (2021) · The Lancet

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 1,983

EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies

Ramos-Casals, M., Brito-Zerón, P., Bombardieri, S., Bootsma, H., De Vita, S., Dörner, T., Fisher, B. A., Gottenberg, J.-E., Hernandez-Molina, G., Kocher, A., et al. (2020) · Annals of the Rheumatic Diseases

Salivary Gland Disorders and FunctionsOcular Surface and Contact Lens

Cited by 732

Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjogren's syndrome

Bowman, S. J., Everett, C. C., O'Dwyer, J. L., Emery, P., Pitzalis, C., Ng, W., Pease, C. T., Price, E. J., Sutcliffe, N., Gendi, N. S. T., et al. (2017) · Arthritis & Rheumatology

Salivary Gland Disorders and FunctionsSystemic Lupus Erythematosus Research

Cited by 276

Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology

Nayar, S., Campos, J., Smith, C. G., Iannizzotto, V., Gardner, D. H., Mourcin, F., Roulois, D., Turner, J., Sylvestre, M., Asam, S., et al. (2019) · Proceedings of the National Academy of Sciences

T-cell and B-cell ImmunologyIL-33, ST2, and ILC Pathways

Cited by 203